Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Protein kinase C theta type | ||
Ligand | BDBM50517666 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1869432 (CHEMBL4370498) | ||
IC50 | 1.9±n/a nM | ||
Citation | Kunikawa, S; Tanaka, A; Takasuna, Y; Tasaki, M; Chida, N Discovery of 2,4-diamino-5-cyanopyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions. Bioorg Med Chem27:790-799 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Protein kinase C theta type | |||
Name: | Protein kinase C theta type | ||
Synonyms: | KPCT_HUMAN | PRKCQ | PRKCT | Protein kinase C theta | Protein kinase C theta type (PRKCQ) | Protein kinase C, PKC; classical/novel | nPKC-theta | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 81878.04 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Full-length human PKC theta (Panvera Catalog No. P2996). | ||
Residue: | 706 | ||
Sequence: |
| ||
BDBM50517666 | |||
n/a | |||
Name | BDBM50517666 | ||
Synonyms: | CHEMBL4585918 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H37F3N6O | ||
Mol. Mass. | 554.6496 | ||
SMILES | FC(F)(F)Oc1ccccc1CNc1ncc(C#N)c(NCC23CC4CC(C2)C(NC2CCCCC2)C(C4)C3)n1 |TLB:37:36:27:25.24.23,THB:29:28:27:25.24.23,37:24:28.36.38:27,23:24:28:38.22.27,23:22:28:25.37.24,(38.54,-18.1,;38.53,-16.69,;37.29,-17.72,;39.79,-17.71,;38.53,-15.15,;37.19,-14.38,;35.86,-15.16,;34.52,-14.38,;34.52,-12.84,;35.86,-12.08,;37.19,-12.85,;38.52,-12.08,;38.52,-10.54,;39.86,-9.77,;41.19,-10.54,;42.53,-9.77,;42.52,-8.22,;43.85,-7.44,;45.18,-6.67,;41.19,-7.46,;41.18,-5.92,;39.85,-5.15,;38.51,-5.92,;38.94,-7.37,;37.74,-8.32,;36.6,-7.45,;36.14,-6.11,;37.29,-5.17,;34.4,-5.99,;32.95,-5.46,;31.77,-6.46,;30.32,-5.92,;29.15,-6.91,;29.41,-8.43,;30.86,-8.96,;32.04,-7.96,;35.67,-6.89,;36.11,-8.34,;36.89,-5.88,;39.86,-8.23,)| | ||
Structure |